Alexia Chatziparasidou – Embryolab DE

Alexia Chatziparasidou B.Sc., M.Sc. PMI-RMP

Biologin, Sr. Klinische Embryologin, akkreditiert bei der ESHRE, Laborleiterin bei Embyolab

Alexia Chatziparasidou, Sr., M.Sc. ist Klinische Embryologin mit einer Erfahrung von mehr als 45.000 Zyklen von In-Vitro-Fertilisationen.

Im Mittelpunkt ihres wissenschaftlichen Interesses steht vor allem die Anwendung moderner Verfahren zur Kryokonservierung von Eizellen und Embryonen, die Behandlung der männlichen Subfertilität und Azoospermie sowie die Entwicklung von Verfahren für Co-Kulturen mit homologen Endometriumzellen.

Sie ist Mitglied in internationalen Organisationen und beteiligt sich an Kooperationen für die genetische Präimplantationsdiagnose, die Patientenberatung und die Untersuchung von Fertilitätsstörungen. Sie ist Mitglied der European Society of Human Reproduction and Embryology (ESHRE), der American Society for Reproductive Medicine (ASRM), der Scientists in Reproductive Medicine (ALPHA), der Society for Cryobiology, des Panhellenischen Andrologenverbandes, des Panhellenischen Verbandes der Biowissenschaftler (PEB) und des Panhellenischen Verbandes Klinischer Embryologen (PEKE).

Sie ist verheiratet und Mutter von zwei Kindern. Sie liebt wissenschaftliche und belletristische Literatur. Sie reist durch alle Welt und empfiehlt die Embryolab Academy und die Praktiken des Qualitäts- und Risikomanagements. Sie akzeptiert jede neue Idee bei Embryolab unter einer Grundvoraussetzung: dem Respekt vor dem Traum der Menschen, die sich uns anvertrauen, um Eltern zu werden!

Wichtige Stationen

2011-heute
Mitbegründerin der Embryolab Academy, Thessaloniki.
2008
Leitende Klinische Embryologin, European Society of Human Reproduction and Embryology (ESHRE).
2006
Postgraduiertengrad (M.Sc.) mit Auszeichnung: „Klinische Embryologie und Technologie der assistierten Reproduktion“, Fachbereich Medizin & Gesundheit, Institut für Herz-Kreislauf- und Stoffwechselerkrankungen, Universität Leeds, UK.
2004-heute
Mitbegründerin & Direktorin, Embryolab, Station für medizinisch assistierte Reproduktion, Thessaloniki.
2004
Mitarbeiterin, Station für assistierte Reproduktion, Fakultät für Medizin, Universität Thessalien, Larisa.
1996
Betreibt ein Labor für assistierte Reproduktion, Larisa.
1995-2002
Klinische Embryologin, private Station für assistierte Reproduktion, Thessaloniki.
1993-1995
Ausbildung in der assistierten Reproduktion, 4. Universitätsklinik für Gynäkologie und Geburtshilfe, Station für assistierte Reproduktion, Hippokrates-Klinik, Thessaloniki.
1992
Abschluss in Biologie, Fachbereich Biologie, Naturwissenschaftliche Fakultät, Aristoteles-Universität Thessaloniki.

Publikationen - Kongresse

Publikationen & Artikel in Zeitschriften

Chatziparasidou A., Christoforidis N., Samolada G., Nijs M. (2014). “Sperm aneuploidy in infertile male patients: a systematic review of the literature”. Andrologia. In press

Chatziparasidou A., Nijs M., Moisidou M., Chara O., Ioakeimidou C., Pappas C., Christoforidis N. (2013). “Accumulation of oocytes and/or embryos by vitrification: a new strategy for managing poor responder patients undergoing pre implantation diagnosis”. F1000Res, 2, 240.

Chatziparasidou A., Moissidou M., Oraiopoulou C., Ioakeimidou C., Pappas C., Nijs M., Christoforidis N. (2013). “The use of PGD in vitriﬁed oocytes and embryos after repeat ovarian stimulation cycles in poor responder patients”. Reproductive Biomedicine Online, 26, Supplement no. 1.

Chatziparasidou A. (2004). “Micromanipulation and Azoospermia: 10 years of experience” (in Greek). ΑΝΗΡ, 3,129-134.

Chatziparasidou A. (2004). “The fate of paternal mitochondria during micromanipulation in human” (in Greek). ΑΝΗΡ, 3, 135-136.

Prapas Y., Prapas N., Chatziparasidou A., Vanderzwalmen P., Nijs M., Prapa S., Vlassis G. (2001). “Ultrasound-guided embryo transfer maximizes the IVF results on day 3 and day 4 embryo transfer but has no impact on day 5″. Hum Reprod, 16(9), 1904-1908.

Prapas Y., Chatziparasidou A., Vanderzwalmen P., Nijs M., Prapas N., Lejeune B., Schoysman R. (1999). “Spermatid injection: reconsidering spermatid injection”. Hum Reprod, 14(9), 2186-2188.

Prapas Y., Prapas N., Jones E. E., Duleba A. J., Olive D. L., Chatziparasidou A., Vlassis G. (1998). “The window for embryo transfer in oocyte donation cycles depends on the duration of progesterone therapy”. Hum Reprod, 13(3), 720-723.

Vanderzwalmen P., Nijs M., Stecher A., Zech H., Bertin G., Lejeune B., Chatziparasidou A., Schoysman R. (1998). “Is there a future for spermatid injections?”. Hum Reprod, 13 Suppl 4, 71-84.

Prapas Y., Prapas N., Chatziparasidou A., Prapa S., Nijs M., Vanderzwalmen P., Jones E. E. (1995). “The echoguide embryo transfer maximizes the IVF results”. Acta Eur Fertil, 26(3), 113-115.

Prapas Y., Prapas N., Chatziparasidou A., Konstantinou P., Vlassis G. (1993). “Ovarian hyperstimulation syndrome and heterotopic pregnancy after IVF”. Acta Eur Fertil, 25(6), 331-333.

Prapas I., Prapas Ν. Chatziparasidou A., Νikoletos Ν. (1995). “Isolation of spermatozoa after Swim up, mini-Percoll and after treatment with human follicular fluid: a comparative study”. Iatriki Paideia (in Greek, Med.Educ.), 3(2) 46-51.

Präsentationen auf Kongressen

(Aushänge und mündliche Ankündigungen)

Chatziparasidou A., Oraiopoulou C., Moisidou M., Ioakeimidou C., Pappas C. Nijs M., Christoforidis N. (2014). “Study of morphokinetic parameters in embryos originating from ejaculated or testicular spermatozoa”. Poster presented in: 10th Biennal Alpha Meeting. Antalya, Turkey.

Chatziparasidou A., Oraiopoulou C., Moisidou M., Ioakeimidou C., Pappas C. Nijs M., Christoforidis N. (2014). “Study of morphokinetic parameters in embryos produced from fresh or frozen testicular spermatozoa”. Poster presented in: 10th Biennal Alpha Meeting. Antalya, Turkey.

Chatziparasidou A., Moisidou M. , Oraiopoulou C. , Ioakeimidou C., Papas C. , Nijs M., Christoforidis N. (2013). “Successful Preimplantation Genetic Diagnosis Program For Poor Responder Patients After Consecutive Ovarian Stimulation Cycles With Cumulative Oocyte Or Embryo Vitrification”. Poster presented in: 12th International Conference on PGD. Instabul, Turkey.

Chatziparasidou A., Moisidou M., Oraiopoulou C., Ioakeimidou C., Pappas C., Nijs M., Christoforidis N. (2013). “Successful preimplantation genetic diagnosis program in poor responder patients after consecutive ovarian stimulation cycles and embryo vitrification”. Poster presented in: 5th International IVI Congress. Sevilla, Spain.

Christoforidis N., Ioakimidou C., Pappas C., Moisidou M., Chatziparasidou A. (2013). “Effectiveness of vitrification in women undergoing elective freezing of oocytes and/or embryos when embryo transfer conditions are suboptimal”. Poster presented in ESHRE Annual meeting. London, UK.

Christoforidis N., Ioakimidou C., Pappas C., Chatziparasidou A. (2013). “P-083 Effectiveness of vitrification in women undergoing elective freezing of oocytes and/or embryos when embryo transfer conditions are suboptimal”. ESHRE, Hum. Reprod. 28 (suppl 1):i152

Christoforidis N., Ioakimidou C., Pappas C., Chatziparasidou A. (2013). “The use of low-dose B-HCG in late follicular phase in controlled ovarian hyperstimulation in oocyte donors”. Conference: COGI Vienna, Austria 24-27/10 2013

Chatziparasidou A., Christoforidis N., Tsakos E., Naitenski R. (2007). “Triplonuclear embryos in ICSI cycles”. Poster presented in:19th World Congress on Fertility and Sterility IFFS. Durban, South Africa.

Chatziparasidou A., Elder K., Christoforidis N., Tsakos E., Nainteski R. (2007). “Seminal Plasma infections”. Poster presented in: 23rd Annual Meeting, ESHRE. Lyon, France.

Chatziparasidou A., Prapas I., Prapas N., Vlassis G. (2000). “Day 5 embryo transfer”. Poster presented in 10th National Meeting in Obstetrics and Gynaecology. Thessaloniki, Greece.

Nijs M., Bosmans E., Chatziparasidou A., Cox A., Jacobs B., Janssen M., Kinget K., Prapas N., Ruis H., Vandereycken G., Wissmann D. and Ombelet W. (2000). “Human blastocyst culture: Factors influencing its results”. Poster presented in: International Congress on Reproductive Medicine, Obstetrics and Gynecology. Tel-Aviv, Israel.

Chatziparasidou A., Prapas I., Prapas N., Vlassis G. (2000). “Intracytoplasmic Sperm injection in couples with oligoasthenozoospermia and azoospermia”. 10th National Meeting in Obstetrics and Gynaecology. Thessaloniki, Greece.

Chatziparasidou A., Prapas I., Prapas N., Vlassis G. (2000). “Azoospermia: Microinjection with fresh and frozen testicular spermatozoa”. Oral Presentation in: 10th National Meeting in Obstetrics and Gynaecology. Thessaloniki, Greece.

Drakopoulos A., Prapas Ν., Prapas Ι., Chatziparasidou Α., Nijs M. and Vanderzwalmen P. (1996). “TESE and ICSI in cases with azoospermia”. Poster presented in: 2nd National Andrology Meeting.Thessaloniki, Greece.

Prapas Y., Chatziparasidou A., Vanderzwalmen P., Nijs M., Prapas N., Drakopoulos A., Lejeune B., Vlassis G. and Schoysman R. (1997). “Retrieval of spermatozoa and spermatids from testicular tissue in non-obstructive azoospermic patients”. Oral Presentation in: 13th Annual Meeting ESHRE. Edinburg, UK.

Gastrednerin

Chatziparasidou A. (2014, December). “Certification – accreditation – ISO 9001 – ISO 15189 – ABB : what’s in a name, what’s in a number?”. Invited talk in: IVth Annual Symposium of the Assisted Reproduction Programme of the Province of Buenos Aires. Quality and Risk Management in IVF laboratories. Embryolab Academy. Province of Buenos Aires, Argentina.

Chatziparasidou A. (2014, December). “What is risk and how do you assess it? Non-conformity registration in ART”. Invited talk in: IVth Annual Symposium of the Assisted Reproduction Programme of the Province of Buenos Aires. Quality and Risk Management in IVF laboratories. Embryolab Academy. Province of Buenos Aires, Argentina.

Chatziparasidou A. (2014, December). “Air quality: is it that important and if so, how to measure and control it?”. Invited talk in: IVth Annual Symposium of the Assisted Reproduction Programme of the Province of Buenos Aires. Quality and Risk Management in IVF laboratories. Embryolab Academy. Province of Buenos Aires, Argentina.

Chatziparasidou A. (2014, December). “Preventing errors and having traceability in all your laboratory activities and cryostorage systems – how to manage”. Invited talk in: IVth Annual Symposium of the Assisted Reproduction Programme of the Province of Buenos Aires. Quality and Risk Management in IVF laboratories. Embryolab Academy. Province of Buenos Aires, Argentina.

Chatziparasidou A. (2014, July). “Non-conformity registration in ART: what are the lessons to learn?”. Invited talk in: International Workshop on Quality and Risk Management in your IVF laboratories: from theory to practice, Embryolab Academy. Thessaloniki, Greece.

Chatziparasidou A. (2014, March). “Air quality: is it that important and if so, how to measure and control it?”. Invited talk in: International Workshop on Quality and Risk Management in your IVF laboratories: from theory to practice, Embryolab Academy. Thessaloniki, Greece.

Chatziparasidou A. (2013, September). “Aneuploidy in male infertile patients: indications and results”. Invited talk in: International Workshop on ‘Preimplantation Genetic Diagnosis 2013’, Embryolab Academy. Thessaloniki, Greece.

Chatziparasidou A. (2013, September). “Oocyte and embryo biopsy: technical aspects”. Invited talk in International Workshop on ‘Preimplantation Genetic Diagnosis 2013’, Embryolab Academy. Thessaloniki, Greece.

Chatziparasidou A. (2013, September). “Blastomere and trophectoderm biopsy”. Invited talk in: International Workshop on ‘Preimplantation Genetic Diagnosis 2013’, Embryolab Academy. Thessaloniki, Greece.

Chatziparasidou A., Nagy P. (2013, September). “Can the human oocyte be ‘micro-manipulated’?”/ Invited talk in: 4th Biennial Alpha Conference, 8th Meeting of Andrology in the 2000s, Genk Institute for Fertility Technology. Antwerp, Belgium.

Nikos Christoforidis MD, MSc, FRCOG